<p>Fresenius Medical Care AG（ETR:FME - 获取免费报告）的股票在周四的交易中突破了其 200 日移动平均线。该股票的 200 日移动平均线为€42.56（$47.29），最高交易价为€45.73（$50.81）。Fresenius Medical Care 的股票最后交易价为€45.57（$50.63），成交量为 408,811 股。</p>
<p>获取 <strong>Fresenius Medical Care</strong> 的提醒：</p>
<h2>Fresenius Medical Care 价格表现</h2>
<p>该股票的 50 日移动平均线为€45.58，200 日移动平均线为€42.56。公司的债务与股本比率为 82.24，速动比率为 0.80，流动比率为 1.37。该股票的市值为 137.9 亿美元，市盈率为 20.93，市盈增长比率为 0.42，贝塔值为 0.86。</p>
<h2>Fresenius Medical Care 公司简介</h2>
<p>（获取免费报告）</p>
<p>Fresenius Medical Care AG 在德国、北美及国际上为肾脏疾病患者提供透析及相关服务。该公司通过门诊透析诊所网络提供透析治疗及相关实验室和诊断服务；提供材料、培训和患者支持服务，包括临床监测、后续协助以及安排将物资送到患者住所；并为美国医院的住院终末期肾病（ESRD）患者和急性肾衰竭患者提供合同透析服务。</p>
<h2>推荐故事</h2>
<ul>
<li>我们更看好的五只股票，胜过 Fresenius Medical Care</li>
<li>什么是股息挑战者？</li>
<li>RH 的股票下跌近 40%：投资者现在可以转向哪里</li>
<li>技术指标如何帮助你找到被超卖的股票</li>
<li>关税、分拆和 R2 更新是 Rivian 的积极信号</li>
<li>股票回购是什么？投资者的全面指南</li>
<li>Cathie Wood 大量购买百度——现在是购买的合适时机吗？</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资$1,000 在 Fresenius Medical Care 吗？</h2>
<p>在考虑 Fresenius Medical Care 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户在更广泛市场注意到之前立即购买的股票……而 Fresenius Medical Care 并不在名单上。</p>
<p>虽然 Fresenius Medical Care 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

<p>Fresenius Medical Care（ETR:FME）股票已突破其 200 日移动平均线 42.56 欧元，目前交易价格为 45.57 欧元，市值为 137.9 亿美元。该股票的市盈率为 20.93，贝塔值为 0.86。分析师目前将其评级为持有，但建议有更好的投资选择。该公司专注于为各个地区的肾病患者提供透析服务</p>

<p>Shares of Fresenius Medical Care AG (ETR:FME - Get Free Report) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of €42.56 ($47.29) and traded as high as €45.73 ($50.81). Fresenius Medical Care shares last traded at €45.57 ($50.63), with a volume of 408,811 shares traded.</p>
<div class="lb-trans"><p>Fresenius Medical Care AG（ETR:FME - 获取免费报告）的股票在周四的交易中突破了其 200 日移动平均线。该股票的 200 日移动平均线为€42.56（$47.29），最高交易价为€45.73（$50.81）。Fresenius Medical Care 的股票最后交易价为€45.57（$50.63），成交量为 408,811 股。</p>
</div><p>Get <strong>Fresenius Medical Care</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Fresenius Medical Care</strong> 的提醒：</p>
</div><h2>Fresenius Medical Care Price Performance</h2>
<div class="lb-trans"><h2>Fresenius Medical Care 价格表现</h2>
</div><p>The stock's 50 day moving average is €45.58 and its two-hundred day moving average is €42.56. The company has a debt-to-equity ratio of 82.24, a quick ratio of 0.80 and a current ratio of 1.37. The stock has a market capitalization of $13.79 billion, a PE ratio of 20.93, a price-to-earnings-growth ratio of 0.42 and a beta of 0.86.</p>
<div class="lb-trans"><p>该股票的 50 日移动平均线为€45.58，200 日移动平均线为€42.56。公司的债务与股本比率为 82.24，速动比率为 0.80，流动比率为 1.37。该股票的市值为 137.9 亿美元，市盈率为 20.93，市盈增长比率为 0.42，贝塔值为 0.86。</p>
</div><h2>Fresenius Medical Care Company Profile</h2>
<div class="lb-trans"><h2>Fresenius Medical Care 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.</p>
<div class="lb-trans"><p>Fresenius Medical Care AG 在德国、北美及国际上为肾脏疾病患者提供透析及相关服务。该公司通过门诊透析诊所网络提供透析治疗及相关实验室和诊断服务；提供材料、培训和患者支持服务，包括临床监测、后续协助以及安排将物资送到患者住所；并为美国医院的住院终末期肾病（ESRD）患者和急性肾衰竭患者提供合同透析服务。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than Fresenius Medical Care</li>
<li>What Are Dividend Challengers?</li>
<li>Shares of RH Down Nearly 40%: Where Investors Can Turn To Now</li>
<li>How Technical Indicators Can Help You Find Oversold Stocks</li>
<li>Tariffs, Spin-Out, and R2 Updates Are Positive Signs for Rivian</li>
<li>What is a buyback in stocks? A comprehensive guide for investors</li>
<li>Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy?</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，胜过 Fresenius Medical Care</li>
<li>什么是股息挑战者？</li>
<li>RH 的股票下跌近 40%：投资者现在可以转向哪里</li>
<li>技术指标如何帮助你找到被超卖的股票</li>
<li>关税、分拆和 R2 更新是 Rivian 的积极信号</li>
<li>股票回购是什么？投资者的全面指南</li>
<li>Cathie Wood 大量购买百度——现在是购买的合适时机吗？</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Fresenius Medical Care Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资$1,000 在 Fresenius Medical Care 吗？</h2>
</div><p>Before you consider Fresenius Medical Care, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Fresenius Medical Care 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fresenius Medical Care wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户在更广泛市场注意到之前立即购买的股票……而 Fresenius Medical Care 并不在名单上。</p>
</div><p>While Fresenius Medical Care currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Fresenius Medical Care 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

费森尤斯医疗（ETR:FME）股价突破 200 日移动平均线 - 你应该卖出吗？